Binding assay for the diagnosis of a heparin-induced thrombocytopenia
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
May 3, 2022
Grant Date -
Feb 7, 2019
app pub date -
Jul 27, 2018
filing date -
Jul 27, 2018
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The present disclosure is in the field of in vitro diagnostics and relates to an easily automatable binding assay for establishing a heparin-induced thrombocytopenia, which binding assay uses FcγRIIa protein-coated particles.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- G01N Class
- 0 % this patent is cited more than
- 3 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Nov 3, 2025 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Nov 3, 2029 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Nov 3, 2033 |